These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22355905)

  • 1. Tumor fighter.
    Kiser K
    Minn Med; 2012 Jan; 95(1):16-9. PubMed ID: 22355905
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer vaccines: a novel strategy to sensitize malignant glioma to chemotherapy.
    Liu G; Yu JS
    Expert Rev Neurother; 2007 Oct; 7(10):1235-7. PubMed ID: 17939761
    [No Abstract]   [Full Text] [Related]  

  • 3. Early-stage progress on glioma vaccines.
    Brower V
    J Natl Cancer Inst; 2011 Sep; 103(18):1361-2. PubMed ID: 21881038
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccines for glioblastoma and high-grade glioma.
    Wheeler CJ; Black KL
    Expert Rev Vaccines; 2011 Jun; 10(6):875-86. PubMed ID: 21692706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized, multivalent, and more affordable: the globalization of vaccines.
    Debinski W
    Clin Cancer Res; 2005 Aug; 11(16):5663-4. PubMed ID: 16115899
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogene therapy as a treatment for malignant brain tumors in young mice.
    Glick RP; Lichtor T; Lin H; Tarlock K; Cohen EP
    J Neurosurg; 2006 Jul; 105(1 Suppl):65-70. PubMed ID: 16871873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibodies to glial fibrillary antigen as potential carriers of drugs for glial tumors].
    Obukhov SK; Kalashnikova VV; Khalanskiĭ AS
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (2):30-2. PubMed ID: 2787569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic analysis of in vitro and in vivo brain tumor models.
    Schuster JM; Friedman HS; Bigner DD
    Neurol Clin; 1991 May; 9(2):375-82. PubMed ID: 1944106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model.
    Lumniczky K; Desaknai S; Mangel L; Szende B; Hamada H; Hidvegi EJ; Safrany G
    Cancer Gene Ther; 2002 Jan; 9(1):44-52. PubMed ID: 11916244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.
    Estella-Hermoso de Mendoza A; Préat V; Mollinedo F; Blanco-Prieto MJ
    J Control Release; 2011 Dec; 156(3):421-6. PubMed ID: 21821074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats.
    Tian W; Ying X; Du J; Guo J; Men Y; Zhang Y; Li RJ; Yao HJ; Lou JN; Zhang LR; Lu WL
    Eur J Pharm Sci; 2010 Oct; 41(2):232-43. PubMed ID: 20600880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma.
    Yajima N; Yamanaka R; Mine T; Tsuchiya N; Homma J; Sano M; Kuramoto T; Obata Y; Komatsu N; Arima Y; Yamada A; Shigemori M; Itoh K; Tanaka R
    Clin Cancer Res; 2005 Aug; 11(16):5900-11. PubMed ID: 16115932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination.
    Yu JS; Luptrawan A; Black KL; Liu G
    Clin Neurosurg; 2006; 53():345-51. PubMed ID: 17380773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immunity in the treatment of brain tumors.
    Wheeler CJ; Yu JS; Black KL
    Clin Neurosurg; 2004; 51():132-9. PubMed ID: 15571138
    [No Abstract]   [Full Text] [Related]  

  • 15. Trabedersen, a TGFbeta2-specific antisense oligonucleotide for the treatment of malignant gliomas and other tumors overexpressing TGFbeta2.
    Vallières L
    IDrugs; 2009 Jul; 12(7):445-53. PubMed ID: 19579166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials referral resource. Multicenter phase I and II trials in adults with high-grade gliomas.
    Kaplan RS; Smiley JK; Cheson BD
    Oncology (Williston Park); 1999 Apr; 13(4):532-3, 537. PubMed ID: 10234703
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-glioma vaccination].
    Delhaye M; Clavreul A; Garcion E; Menei P
    Neurochirurgie; 2003 Sep; 49(4):459-63. PubMed ID: 14526258
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel chemotherapeutics and other therapies for treating high-grade glioma.
    Kang JH; Adamson C
    Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride on experimental brain tumors.
    Hasegawa H; Shapiro WR; Posner JB; Basler G
    Cancer Res; 1979 Jul; 39(7 Pt 1):2687-90. PubMed ID: 445472
    [No Abstract]   [Full Text] [Related]  

  • 20. The contenders. Vaccines and viruses take aim at cancer cells.
    Clancy F
    Minn Med; 2005 Apr; 88(4):24-8. PubMed ID: 15940888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.